Research progress on multiple cell death pathways of podocytes in diabetic kidney disease

被引:0
作者
Can Yang
Zhen Zhang
Jieting Liu
Peijian Chen
Jialing Li
Haiying Shu
Yanhui Chu
Luxin Li
机构
[1] Mudanjiang Medical University,Heilongjiang Key Laboratory of Anti
[2] Mudanjiang Medical University,Fibrosis Biotherapy
[3] Mudanjiang Medical University,College of Life Sciences
来源
Molecular Medicine | / 29卷
关键词
Diabetic kidney disease; Podocyte; Apoptosis; Autophagy; Endoplasmic reticulum stress; Pyroptosis; Necroptosis; Ferroptosis; Mitotic catastrophe;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetic kidney disease (DKD) is the main cause of end-stage renal disease, and its clinical manifestations are progressive proteinuria, decreased glomerular filtration rate, and renal failure. The injury and death of glomerular podocytes are the keys to DKD. Currently, a variety of cell death modes have been identified in podocytes, including apoptosis, autophagy, endoplasmic reticulum (ER) stress, pyroptosis, necroptosis, ferroptosis, mitotic catastrophe, etc. The signaling pathways leading to these cell death processes are interconnected and can be activated simultaneously or in parallel. They are essential for cell survival and death that determine the fate of cells. With the deepening of the research on the mechanism of cell death, more and more researchers have devoted their attention to the underlying pathologic research and the drug therapy research of DKD. In this paper, we discussed the podocyte physiologic role and DKD processes. We also provide an overview of the types and specific mechanisms involved in each type of cell death in DKD, as well as related targeted therapy methods and drugs are reviewed. In the last part we discuss the complexity and potential crosstalk between various modes of cell death, which will help improve the understanding of podocyte death and lay a foundation for new and ideal targeted therapy strategies for DKD treatment in the future.
引用
收藏
相关论文
共 450 条
  • [1] Alicic RZ(2017)Diabetic kidney disease: challenges, progress, and possibilities Clin J Am Soc Nephrol 12 2032-2045
  • [2] Rooney MT(2019)Podocytes: way to go Am J Pathol 189 226-228
  • [3] Tuttle KR(2005)Standards of medical care in diabetes Diabetes Care 28 S4-S36
  • [4] Altintas MM(2014)Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus Front Endocrinol (lausanne) 5 151-376
  • [5] Reiser J(2018)Long noncoding RNA LINC01619 regulates microRNA-27a/Forkhead box protein o1 and endoplasmic reticulum stress-mediated podocyte injury in diabetic nephropathy Antioxid Redox Signal 29 355-520
  • [6] American DA(2022)Mechanisms of podocyte injury and implications for diabetic nephropathy Clin Sci (lond) 136 493-1446
  • [7] Anil Kumar P(2021)Insights into glomerular filtration and albuminuria N Engl J Med 384 1437-370
  • [8] Welsh GI(2014)Unravelling mechanisms of p53-mediated tumour suppression Nat Rev Cancer 14 359-1948
  • [9] Saleem MA(2020)Podocytes maintain high basal levels of autophagy independent of mtor signaling Autophagy 16 1932-1627
  • [10] Menon RK(2016)JAK inhibition in the treatment of diabetic kidney disease Diabetologia 59 1624-495